Thelansis

  Restless Legs Syndrome (RLS) Market Outlook Thelansis’s “Restless Legs Syndrome (RLS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Restless Legs Syndrome (RLS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Restless Legs Syndrome (RLS) Overview Restless legs syndrome (RLS) is a neurological condition that causes an uncomfortable or unpleasant sensation in the legs and an irresistible urge to move them. It is also known as Willis-Ekbom disease. The symptoms typically begin in the late afternoon or evening and worsen at night, often interfering with sleep. This can make falling asleep or returning to sleep after waking up c...

  Restless legs syndrome (RLS) is a neurological condition that makes the patient feel uncomfortable or unpleasant inpatient legs and compels the patient to move. Restless legs syndrome includes idiopathic RLS, primary RLS, and Willis-Ekbom Disease. The symptoms usually start in the late afternoon or evening and worsen at night when you sleep. Falling or returning to sleep after waking up might be challenging. Walking or moving the legs usually helps ease the pain, but the symptoms frequently return as the action is stopped. Because the symptoms of RLS are brought on by resting and trying to fall asleep, it is both a movement disorder and a sleep disorder because the affected individuals must move their legs to reduce symptoms. Although it affects both sexes equally, females are likelier to have it. The majority of severely affected people are middle-aged or older, and as people age, the symptoms usually get worse and occur more frequently. The first-line prescription medications...